Vancomycin Heteroresistance and Methicillin-Resistant Staphylococcus aureus

被引：45

作者：

Deresinski, Stan ^{[1
,2
]}

机构：

[1] Stanford Univ, Div Infect Dis & Geog Med, Stanford, CA USA

[2] Santa Clara Valley Med Ctr, Div Infect Dis, San Jose, CA 95128 USA

来源：

JOURNAL OF INFECTIOUS DISEASES | 2009年 / 199卷 / 05期

关键词：

BACTERICIDAL ACTIVITY; REDUCED SUSCEPTIBILITY; HETEROGENEOUSLY RESISTANT; INTRACELLULAR ACTIVITIES; INTERMEDIATE RESISTANCE; CLINICAL-SIGNIFICANCE; DAPTOMYCIN; BACTEREMIA; EXPRESSION; PERSISTENT;

D O I：

10.1086/596630

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：605 / 609

页数：5

共 48 条

[1] Vancomycin in surgical infections due to meticillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin [J].

Ariza, J ;

Pujol, M ;

Cabo, J ;

Peña, C ;

Fernández, N ;

Liñares, J ;

Ayats, J ;

Gudiol, F .

LANCET, 1999, 353 (9164) :1587-1588

[2] Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages [J].

Barcia-Macay, M ;

Seral, C ;

Mingeot-Leclercq, MP ;

Tulkens, PM ;

Van Bambeke, F .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) :841-851

[3] Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus [J].

Barcia-Macay, Maritza ;

Lemaire, Sandrine ;

Mingeot-Leclercq, Marie-Paule ;

Tulkens, Paul M. ;

Van Bambeke, Francoise .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (06) :1177-1184

[4] Prevalence, molecular epidemiology, and clinical significance of heterogeneous glycopeptide-intermediate Staphylococcus aureus in liver transplant recipients [J].

Bert, F ;

Clarissou, J ;

Durand, F ;

Delefosse, D ;

Chauvet, C ;

Lefebvre, P ;

Lambert, N ;

Branger, C .

JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (11) :5147-5152

[5] agr-mediated dispersal of Staphylococcus aureus biofilms [J].

Boles, Blaise R. ;

Horswill, Alexander R. .

PLOS PATHOGENS, 2008, 4 (04)

[6] Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus [J].

Charles, PGP ;

Ward, PB ;

Johnson, PDR ;

Howden, BP ;

Grayson, ML .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) :448-451

[7] Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus [J].

Cui, LZ ;

Tominaga, E ;

Neoh, HM ;

Hiramatsu, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) :1079-1082

[8] Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus [J].

Cui, LZ ;

Iwamoto, A ;

Lian, JQ ;

Neoh, HM ;

Maruyama, T ;

Horikawa, Y ;

Hiramatsu, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) :428-438

[9]

DASKALAKI M, 2008, 8 EUR C CLIN MICR IN

[10] A global view of Staphylococcus aureus whole genome expression upon internalization in human epithelial cells [J].

Garzoni, Christian ;

Francois, Patrice ;

Huyghe, Antoine ;

Couzinet, Sabine ;

Tapparel, Caroline ;

Charbonnier, Yvan ;

Renzoni, Adriana ;

Lucchini, Sacha ;

Lew, Daniel P. ;

Vaudaux, Pierre ;

Kelley, William L. ;

Schrenzel, Jacques .

BMC GENOMICS, 2007, 8 (1)

← 1 2 3 4 5 →